CE Mark is the first major regulatory milestone for Nanox.ARC Imaging System in the European market; follows recent general use FDA clearance in the U.S. New clinical data supporting use of Nanox ...

Nanox Imaging Ltd. announced promising results from a clinical study showcasing its Nanox.ARC digital tomosynthesis system, which enhances musculoskeletal imaging and outperforms conventional ...

CE Mark is the first major regulatory milestone for Nanox.ARC Imaging System in the European market; follows recent general use FDA clearance in the U.S. New clinical data supporting use of Nanox.ARC ...

Medical tech company Nano-X Imaging Ltd. (Nasdaq: NNOX) said Nanox.ARC, its digital multi-source 3D tomosynthesis imaging system, received CE mark certification in the European market. Nanox.ARC ...

NANO-X IMAGING (NNOX) will present data supporting the Nanox.ARC performance at the 2025 European Congress of Radiology, taking place February 26 – March 2 in Vienna, Austria. The Nanox.ARC is a ...

“This certification for whole-body imaging in Europe, combined with our existing distributors and ongoing pursuit of strategic partnerships, positions us to accelerate the Nanox.ARC’s ...

In a clinical study, it was found that the Nanox.ARC digital tomosynthesis enhanced musculoskeletal imaging, can improve the sensitivity and specificity of conventional radiography. In addition, can ...

In a clinical study, it was found that the Nanox.ARC digital tomosynthesis enhanced musculoskeletal imaging, can improve the sensitivity and specificity of conventional radiography. In addition ...